First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 781 000 KRW Market Closed
Updated: May 15, 2024

Samsung Biologics Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samsung Biologics Co Ltd
Interest Income Expense Peer Comparison

Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Interest Income Expense
₩1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Interest Income Expense
-₩55.1m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Interest Income Expense
₩959.6m
CAGR 3-Years
-26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Interest Income Expense
-₩10.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Interest Income Expense
₩1.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Interest Income Expense
₩5B
CAGR 3-Years
-38%
CAGR 5-Years
39%
CAGR 10-Years
31%

See Also

What is Samsung Biologics Co Ltd's Interest Income Expense?
Interest Income Expense
1.5B KRW

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Interest Income Expense amounts to 1.5B KRW.